EyeCheckup is a promising startup revolutionizing the healthcare industry with its cutting-edge Artificial Intelligence technology aimed at preventing vision loss. Founded in 2020, this United Kingdom-based company leverages AI to provide an early diagnosis of major retinal diseases such as Diabetic Retinopathy, Glaucoma, and Age-related Macula Degeneration via retinal fundus imaging.
The company has positioned itself within the intersection of the AI and Health Care industries, offering innovative solutions that promise to alleviate the global burden of vision impairment. As of 08 December 2023, EyeCheckup received a $650.00K Seed Round investment, led by Arz Portfolio. This funding marks a significant milestone, underscoring strong investor confidence in their technology-driven approach to vision diagnosis. Investors seeking AI-driven healthcare innovations will find EyeCheckup a company worth watching.